Raymond James Financial Inc Blueprint Medicines Corp Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 241,966 shares of BPMC stock, worth $26.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
241,966Holding current value
$26.5 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
356Shares Held
60.8MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$733 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$729 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$591 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$435 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$303 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.55B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...